Inhibiting heat shock factor 1 in human cancer cells with a potent RNA aptamer.
Heat shock factor 1 (HSF1) is a master regulator that coordinates chaperone protein expression to enhance cellular survival in the face of heat stress. In cancer cells, HSF1 drives a transcriptional program distinct from heat shock to promote metastasis and cell survival. Its strong association with...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4011729?pdf=render |
id |
doaj-127516bd905c41b089b6c83fc9092642 |
---|---|
record_format |
Article |
spelling |
doaj-127516bd905c41b089b6c83fc90926422020-11-25T01:55:16ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0195e9633010.1371/journal.pone.0096330Inhibiting heat shock factor 1 in human cancer cells with a potent RNA aptamer.H Hans SalamancaMarc A AntonyakRichard A CerioneHua ShiJohn T LisHeat shock factor 1 (HSF1) is a master regulator that coordinates chaperone protein expression to enhance cellular survival in the face of heat stress. In cancer cells, HSF1 drives a transcriptional program distinct from heat shock to promote metastasis and cell survival. Its strong association with the malignant phenotype implies that HSF1 antagonists may have general and effective utilities in cancer therapy. For this purpose, we had identified an avid RNA aptamer for HSF1 that is portable among different model organisms. Extending our previous work in yeast and Drosophila, here we report the activity of this aptamer in human cancer cell lines. When delivered into cells using a synthetic gene and strong promoter, this aptamer was able to prevent HSF1 from binding to its DNA regulation elements. At the cellular level, expression of this aptamer induced apoptosis and abolished the colony-forming capability of cancer cells. At the molecular level, it reduced chaperones and attenuated the activation of the MAPK signaling pathway. Collectively, these data demonstrate the advantage of aptamers in drug target validation and support the hypothesis that HSF1 DNA binding activity is a potential target for controlling oncogenic transformation and neoplastic growth.http://europepmc.org/articles/PMC4011729?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
H Hans Salamanca Marc A Antonyak Richard A Cerione Hua Shi John T Lis |
spellingShingle |
H Hans Salamanca Marc A Antonyak Richard A Cerione Hua Shi John T Lis Inhibiting heat shock factor 1 in human cancer cells with a potent RNA aptamer. PLoS ONE |
author_facet |
H Hans Salamanca Marc A Antonyak Richard A Cerione Hua Shi John T Lis |
author_sort |
H Hans Salamanca |
title |
Inhibiting heat shock factor 1 in human cancer cells with a potent RNA aptamer. |
title_short |
Inhibiting heat shock factor 1 in human cancer cells with a potent RNA aptamer. |
title_full |
Inhibiting heat shock factor 1 in human cancer cells with a potent RNA aptamer. |
title_fullStr |
Inhibiting heat shock factor 1 in human cancer cells with a potent RNA aptamer. |
title_full_unstemmed |
Inhibiting heat shock factor 1 in human cancer cells with a potent RNA aptamer. |
title_sort |
inhibiting heat shock factor 1 in human cancer cells with a potent rna aptamer. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2014-01-01 |
description |
Heat shock factor 1 (HSF1) is a master regulator that coordinates chaperone protein expression to enhance cellular survival in the face of heat stress. In cancer cells, HSF1 drives a transcriptional program distinct from heat shock to promote metastasis and cell survival. Its strong association with the malignant phenotype implies that HSF1 antagonists may have general and effective utilities in cancer therapy. For this purpose, we had identified an avid RNA aptamer for HSF1 that is portable among different model organisms. Extending our previous work in yeast and Drosophila, here we report the activity of this aptamer in human cancer cell lines. When delivered into cells using a synthetic gene and strong promoter, this aptamer was able to prevent HSF1 from binding to its DNA regulation elements. At the cellular level, expression of this aptamer induced apoptosis and abolished the colony-forming capability of cancer cells. At the molecular level, it reduced chaperones and attenuated the activation of the MAPK signaling pathway. Collectively, these data demonstrate the advantage of aptamers in drug target validation and support the hypothesis that HSF1 DNA binding activity is a potential target for controlling oncogenic transformation and neoplastic growth. |
url |
http://europepmc.org/articles/PMC4011729?pdf=render |
work_keys_str_mv |
AT hhanssalamanca inhibitingheatshockfactor1inhumancancercellswithapotentrnaaptamer AT marcaantonyak inhibitingheatshockfactor1inhumancancercellswithapotentrnaaptamer AT richardacerione inhibitingheatshockfactor1inhumancancercellswithapotentrnaaptamer AT huashi inhibitingheatshockfactor1inhumancancercellswithapotentrnaaptamer AT johntlis inhibitingheatshockfactor1inhumancancercellswithapotentrnaaptamer |
_version_ |
1724984108173492224 |